Venus Concept is a global medical technology company that develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies. Co.'s products include: Venus Legacy, in which the Venus Legacy BX is a noninvasive device intended for use in dermatological and general surgical procedures for females for the noninvasive treatment of moderate to severe facial wrinkles and rhytides in Fitzpatrick Skin Types I-IV; Venus Versa, in which the Venus Versa system is a multi-application device intended for use in aesthetic and cosmetic procedures; and Venus Glow, in which Venus Glow is a motorized dermabrasion device. The VERO stock yearly return is shown above.
The yearly return on the VERO stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2022 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the VERO annual return calculation with any dividends reinvested as applicable (on ex-dates).
|